Xiaojin Wang

Xiaojin Wang

Auto-generated profile, based on publicly available information

Xiaojin Wang

Publishing House of Chinese Hepatology Editorial Department of Journal Shanghai,P. R

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2024 in Hepatology Communications
Verified
Journal Article
Open access
XZXinyan Zhao
Xinyan Zhao
YWYan Wang
Yan Wang
RLRongtao Lai
Rongtao Lai
XWXiaojin Wang
Xiaojin Wang
YYYuecheng Yu
Yuecheng Yu
JJJidong Jia
Jidong Jia
Background & Aims: The Revised Electronic Causality Assessment Method (RECAM), a computerized update of the Roussel Uclaf Causality Assessment Methodology (RUCAM), was recently proposed. In this study, we validated and compared the utility of the RECAM and RUCAM in Chinese patients with a single conventional or herbal agent-induced liver injury. Methods: In this retrospective multicenter cohort of well-established DILI and non-DILI patients from 5 centers in China, the diagnostic performance of the RUCAM and RECAM was compared by AUC analysis. The consistency was evaluated by weighted kappa. The major causes of discrepancy were explored. Results: A total of 481 DILI and 100 non-DILI patients were included. In total, 62.6% of the DILI cases were induced by conventional agents, and 37.4% were induced by herbs. The RECAM had relatively higher AUC than RUCAM for overall [0.947 (0.926–0.964) vs. 0.867 (0.836–0.893), p=0.0016], conventional agents [0.923 (0.890–0.949) vs. 0.819 (0.775–0.858), p=0.0185], and herbs [0.972 (0.941–0.989) vs.0.911 (0.866–0.944), p=0.0199]. Latency, scores associated with hepatitis B, and hepatotoxicity information of the insulting drugs were the 3 main causes for the inconsistency between RECAM and RUCAM scores. Conclusions: The RECAM had relatively better diagnostic performance than RUCAM, with a higher AUC for Chinese DILI patients. Timely updates of the LiverTox category and refinement of serum markers to exclude hepatitis B activity would further improve the applicability of RECAM in areas where the use of herbs and resolution of past HBV infections are common.

20 January 2019
Verified
Journal Article
Closed access
SSS S Sun
S S Sun
YWY X Wu
Y X Wu
MCM L Cheng
M L Cheng
CCC W Chen
C W Chen
YPY S Peng
Y S Peng
QFQ C Fu
Q C Fu

11 January 2025 in Gastroenterology Report
Verified
Journal Article
Open access
XSXiaoru Sun
Xiaoru Sun
LSLiqin Shi
Liqin Shi
RLRongtao Lai
Rongtao Lai
XWXiaojin Wang
Xiaojin Wang
MLMuyun Liu
Muyun Liu

24 October 2019 in Exploratory Research and Hypothesis in Medicine
Verified
Journal Article
Open access
PDF file
ZLZhenyu Li
Zhenyu Li
XWXi Wang
Xi Wang
JCJinwei Chen
Jinwei Chen
ZZZusheng Zang
Zusheng Zang
FZFeng Zhou
Feng Zhou
QFQingchun Fu
Qingchun Fu
To evaluate the effects of gastric coronary venous embolization with TH glue (developer-containing octyl-α-cyanoacrylate) in combination with splenectomy for the treatment of cirrhotic portal hypertension and gastroesophageal varices.